KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Texas Instruments (TXN) Raw Materials (2016 - 2025)

Texas Instruments (TXN) has disclosed Raw Materials for 17 consecutive years, with $465.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 17.72% year-over-year to $465.0 million, compared with a TTM value of $465.0 million through Dec 2025, up 17.72%, and an annual FY2025 reading of $465.0 million, up 17.72% over the prior year.
  • Raw Materials was $465.0 million for Q4 2025 at Texas Instruments, up from $431.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $465.0 million in Q4 2025 and bottomed at $183.0 million in Q1 2021.
  • Average Raw Materials over 5 years is $349.8 million, with a median of $390.5 million recorded in 2023.
  • The sharpest move saw Raw Materials soared 51.74% in 2022, then decreased 5.95% in 2024.
  • Year by year, Raw Materials stood at $245.0 million in 2021, then surged by 44.08% to $353.0 million in 2022, then grew by 18.98% to $420.0 million in 2023, then decreased by 5.95% to $395.0 million in 2024, then increased by 17.72% to $465.0 million in 2025.
  • Business Quant data shows Raw Materials for TXN at $465.0 million in Q4 2025, $431.0 million in Q3 2025, and $402.0 million in Q2 2025.